BioFire’s PCR-based point-of-care diagnostic testing provides urgent care clinics with the power of molecular diagnostics in a rapid, easy-to-use system. Onsite infectious disease diagnostics enables urgent care center to provide patients with fast answers, while giving clinicians the information they need to target treatment decisions.
Right now, SARS-CoV-2 is everyone’s top suspect, but many other respiratory bugs can cause similar, overlapping symptoms. Now you can test for SARS-CoV-2 in patients suspected of COVID-19, along with 18 common respiratory pathogens with syndromic testing from BioFire® Respiratory 2.1-EZ (RP2.1-EZ) Panel—now available under an FDA Emergency Use Authorization. Rapid answers on a broad range of pathogens, in about 45 minutes may help improve patient outcomes.
Core Content in Urgent Care Nursing and Medical Assisting
The Core Content in Urgent Care Nursing and Medical Assisting…